An international team confirms in a pioneering phase 3 clinical trial the decisive role of the time of day on the success of anti-tumour immunotherapies. Huang, Z., Zeng, L., Ruan, Z. et al.
LEADING EDGE MATERIALS’ PROGRESS UPDATE ON ROMANIAN EXPLORATION PROJECT2025 exploration campaign identifies significant areas of mineralisation ...
The Global Electric Vehicle Market has entered a decisive scale-up phase, transitioning from policy-led adoption ...
Explore the capital asset pricing model's (CAPM) insights on risk and return, and its strengths and weaknesses to empower your investment choices.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results